Holen Sie sich die Stockscreener-App
4.19
12.89%
-0.62
Vorhandelsmarkt:
3.60
-0.59
-14.08%
Optimi Health Corp Aktie (OPTH) Neueste Nachrichten
Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance
Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com Australia
Optimi Health ships psilocybin to UK for clinical trial - Investing.com
Optimi Health Completes First Psilocybin Export to UK for Planned Phase 2 Trial - citybuzz -
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - PR Newswire
Optimi Health exports psilocybin to UK for clinical trial By Investing.com - Investing.com South Africa
Optimi Health exports psilocybin to UK for clinical trial - Investing.com UK
Optimi Health Completes First Export of Psilocybin to UK - marketscreener.com
Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial - Quiver Quantitative
OPTH SEC FilingsOptimi Health 10-K, 10-Q, 8-K Forms - Stock Titan
Optimi Health Corp. (OPTH) Price Book Value - Zacks Investment Research
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development - The Malaysian Reserve
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Weekly Voice
Optimi Health stock surges on ibogaine supply deal By Investing.com - Investing.com Australia
Optimi Health stock surges on ibogaine supply deal - Investing.com
US order prioritizes ibogaine; Optimi Health builds GMP supply in Canada - Stock Titan
OPTH Stock Chart | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
OPTH Technical Analysis | Trend, Signals & Chart Patterns | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Optimi Health Corp.Common Shares (Nasdaq:OPTH) Stock Quote - FinancialContent
Optimi Health (OPTH) Stock Forecast and Price Target 2026 - MarketBeat
Optimi Health completes GMP production of psilocybin capsules By Investing.com - Investing.com Canada
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - PR Newswire Canada
Optimi Health completes GMP production of psilocybin capsules - Investing.com UK
OPTH | Optimi Health Corp. Common Institutional Ownership - Quiver Quantitative
OPTH Stock Price, Quote & Chart | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Psilocybin pills prescribed for hard-to-treat depression in Australia - Stock Titan
Price to book ratio of Optimi Health Corp. – DUS:8BN0 - TradingView
Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update - NewMediaWire
What is the current Price Target and Forecast for Optimi Health Corp. (OPTH) - Zacks Investment Research
2.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):